Chimeric (marker) C-strain viruses induce clinical protection against virulent classical swine fever virus (CSFV) and reduce transmission of CSFV between vaccinated pigs

By de Smit A.J.   Bouma A.   van Gennip H.G.P.   de Kluijver E.P.   Moormann R.J.M.  

Vaccine, Vol. 19, Iss. 11, 2001-12 ,pp. : 1467-1476

Elsevier

Access to resources Recommend Favorite

Experimental non-transmissible marker vaccines for classical swine fever (CSF) by trans-complementation of E rns or E2 of CSFV

By van Gennip H.G.P.   Bouma A.   van Rijn P.A.   Widjojoatmodjo M.N.   Moormann R.J.M.  

Vaccine, Vol. 20, Iss. 11, 2002-02 ,pp. : 1544-1556

Elsevier

Access to resources Recommend Favorite

An experimental marker vaccine and accompanying serological diagnostic test both based on envelope glycoprotein E2 of classical swine fever virus (CSFV)

By van Rijn P.A.   van Gennip H.G.P.   Moormann R.J.M.  

Vaccine, Vol. 17, Iss. 5, 1999-02 ,pp. : 433-440

Elsevier

Access to resources Recommend Favorite

Vaccination with a single dose of a recombinant porcine adenovirus expressing the classical swine fever virus gp55 (E2) gene protects pigs against classical swine fever

By Hammond J.M.   McCoy R.J.   Jansen E.S.   Morrissy C.J.   Hodgson A.L.M.   Johnson M.A.  

Vaccine, Vol. 18, Iss. 11, 2000-01 ,pp. : 1040-1050

Elsevier

Access to resources Recommend Favorite

Determination of the onset of the herd-immunity induced by the E2 sub-unit vaccine against classical swine fever virus

By Bouma A.   De Smit A.J.   De Jong M.C.M.   De Kluijver E.P.   Moormann R.J.M.  

Vaccine, Vol. 18, Iss. 14, 2000-02 ,pp. : 1374-1381

Elsevier

Access to resources Recommend Favorite